You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • FRI0194 A phase IB clinical trial with dekavil (F8-IL10), an anti-inflammatory immunocytokine for the treatment of rheumatoid arthritis, used in combination with methotrexate

Article metrics

Article menu
Download PDFPDF
Scientific Abstracts
Poster Presentations
Posters
Rheumatoid arthritis – other biologic treatment
FRI0194 A phase IB clinical trial with dekavil (F8-IL10), an anti-inflammatory immunocytokine for the treatment of rheumatoid arthritis, used in combination with methotrexate

 

Online download statistics by month:

Online download statistics by month: February 2014 to March 2024

AbstractFullPdf
Feb 2014300
Mar 2014500
Apr 2014200
May 2014100
Jul 2014601
Aug 2014200
Oct 2014300
Nov 2014400
Dec 2014200
Jan 2015100
Feb 2015200
Mar 2015500
Apr 2015300
May 2015100
Jun 2015300
Jul 2015300
Aug 2015400
Sep 20151001
Oct 2015303
Nov 2015200
Dec 2015200
Jan 2016400
Apr 2016400
May 2016300
Jun 2016400
Jul 2016400
Aug 2016200
Sep 2016500
Oct 2016301
Nov 2016901
Dec 2016400
Jan 2017500
Feb 2017300
Mar 2017702
Apr 2017300
May 2017801
Jun 20171200
Jul 2017600
Aug 20171400
Sep 20171800
Oct 2017800
Nov 20171600
Dec 2017800
Jan 20181000
Feb 2018200
Mar 20181400
Apr 2018802
May 20181200
Jun 20183000
Jul 2018600
Aug 20182000
Sep 20182600
Oct 20181000
Nov 2018800
Dec 20181200
Jan 20191400
Feb 2019700
Mar 2019500
Apr 2019400
May 2019200
Jul 20192000
Sep 2019201
Oct 2019200
Jan 2020400
Feb 2020200
May 2020100
Jun 20201300
Jul 2020900
Sep 20201001
Nov 2020600
Dec 2020300
Jan 2021200
Mar 2021200
Apr 20211000
Jun 2021300
Oct 2021600
Nov 2021901
Dec 20211701
Jan 2022800
Feb 2022800
Mar 2022800
Apr 2022600
May 2022600
Jun 2022400
Jul 20222200
Aug 2022700
Sep 2022800
Oct 2022700
Nov 20221700
Dec 20221100
Jan 2023600
Feb 20231500
Mar 20231400
Apr 20231203
May 2023300
Jun 2023800
Jul 20231200
Aug 20231200
Sep 20231500
Oct 20232901
Nov 20231700
Dec 20233100
Jan 2024300
Feb 20241200
Mar 20242503
Total854023